Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

albumin

  • Open Access
    Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
    MAKOTO SOHDA, MAKOTO SAKAI, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, NOBUHIRO NAKAZAWA, YASUNARI UBUKATA, KENGO KURIYAM, AKIHIKO SANO, TAKEHIKO YOKOBORI, HIROOMI OGAWA, KEN SHIRABE and HIROSHI SAEKI
    In Vivo July 2022, 36 (4) 1930-1936; DOI: https://doi.org/10.21873/invivo.12914
  • Open Access
    Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, DAISUKE MACHIDA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, KAZUKI KANO, KENTARO HARA, KENKI SEGAMI, ITARU HASHIMOTO, SHINSUKE NAGASAWA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo May 2022, 36 (3) 1424-1431; DOI: https://doi.org/10.21873/invivo.12847
  • You have access
    Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
    HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE and JIN WOO KIM
    In Vivo November 2021, 35 (6) 3423-3430; DOI: https://doi.org/10.21873/invivo.12642
  • You have access
    The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer
    TORU AOYAMA, MASATO NAKAZONO, KENKI SEGAMI, SHINSUKE NAGASAWA, KAZUKI KANO, TAKANOBU YAMADA, YUKIO MAEZAWA, KENTARO HARA, ITARU HASHIMOTO, HIDEAKI SUEMATSU, HAYATO WATANABE, KOSUKE TAKAHASHI, MASAKATSU NUMATA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA
    In Vivo November 2021, 35 (6) 3475-3482; DOI: https://doi.org/10.21873/invivo.12648
  • You have access
    Implications of Low Serum Albumin as a Prognostic Factor of Long-term Outcomes in Patients With Breast Cancer
    TAKAAKI FUJII, SHOKO TOKUDA, YUKO NAKAZAWA, SASAGU KUROZUMI, SAYAKA OBAYASHI, REINA YAJIMA and KEN SHIRABE
    In Vivo July 2020, 34 (4) 2033-2036; DOI: https://doi.org/10.21873/invivo.12003
  • You have access
    Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study
    MAKOTO SAKAI, MAKOTO SOHDA, HIDEYUKI SAITO, YASUNARI UBUKATA, NOBUHIRO NAKAZAWA, KENGO KURIYAMA, KEIGO HARA, AKIHIKO SANO, KYOICHI OGATA, TAKEHIKO YOKOBORI, KEN SHIRABE and HIROSHI SAEKI
    In Vivo March 2020, 34 (2) 881-887; DOI: https://doi.org/10.21873/invivo.11853
  • You have access
    The Predictive Value of the CRP–to–Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study
    JOVAN VUJIC, KATHARINA MARSONER, VALERIE WIENERROITHER, HANS-JORG MISCHINGER and PETER KORNPRAT
    In Vivo November 2019, 33 (6) 2071-2078; DOI: https://doi.org/10.21873/invivo.11706
In Vivo

© 2023 In Vivo

Powered by HighWire